Malgorzata B.
- Country
- Poland
- Department
- Klinika Neurologii Dziecięcej, Pediatrii i Chorób Rzadkich
Research Overview
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Pediatric Patients with Relapsing-Remitting Multiple Sclerosis
- Evaluation of Ocrelizumab Versus Fingolimod in Pediatric and Adolescent Patients with Relapsing-Remitting Multiple Sclerosis: A Phase III Randomized, Double-Blind Study
- Ublituximab in Pediatric Participants with Relapsing forms of Multiple Sclerosis (RMS)
Data & Insights
Has run more than one trial at 5 of 45 partner sites.
Specializations
Pediatric Neurology
The investigator specializes in treating Relapsing-Remitting Multiple Sclerosis (RRMS) in children and adolescents, focusing on innovative therapeutic approaches for young patients with neurological conditions.
- Pediatric Multiple Sclerosis Management
- Neuroimmunological Disorders in Youth
- Neurological Treatment Optimization
Their work encompasses evaluating advanced treatment options for pediatric RRMS patients.
Therapeutic Assessment
The investigator focuses on evaluating pharmacokinetic profiles and pharmacodynamic effects of neurological treatments in younger populations.
- Drug Response Assessment
- Treatment Safety Evaluation
- Therapeutic Monitoring
Their expertise includes analyzing treatment efficacy and safety profiles in pediatric populations.
Comparative Medicine
The investigator examines comparative treatment efficacy between different therapeutic options for pediatric RRMS, with particular attention to clinical outcomes.
- Treatment Comparison Studies
- Clinical Outcome Assessment
- Therapeutic Response Monitoring
Their research includes evaluating relapse rates and treatment responses in young patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.